Cibus (CBUS) FCF Margin Growth (3y) (2019 - 2025)
Cibus (CBUS) FCF Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -3,088.00 |
| 10 | Cibus | 129.72 Mn | 109.29 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 770,984.00 |
| Sep 30, 2025 | 889,021.00 |
| Jun 30, 2025 | 1.22 Mn |
| Mar 31, 2025 | 2.05 Mn |
| Dec 31, 2024 | -93,416.00 |
| Sep 30, 2024 | -78,894.00 |
| Jun 30, 2024 | -204,973.00 |
| Mar 31, 2024 | -229,519.00 |
| Dec 31, 2023 | -105,882.00 |
| Sep 30, 2023 | -493,569.00 |
| Jun 30, 2023 | -565,526.00 |
| Mar 31, 2023 | -512,658.00 |
| Dec 31, 2022 | -878,130.00 |
| Sep 30, 2022 | -1.05 Mn |
| Jun 30, 2022 | -1.18 Mn |
| Mar 31, 2022 | -1.56 Mn |
| Dec 31, 2021 | 32.51 Mn |
| Sep 30, 2021 | 1.57 Mn |
| Jun 30, 2021 | 138,295.00 |
| Mar 31, 2021 | 5.98 Mn |